Get Live Data

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. MTFB.L Share Price
  4. MTFB.L Share Regulatory News
  5. Motif Bio

Pin to quick picksMTFB.L Regulatory News (MTFB)

MTFB.L Information
  • There is currently no data for MTFB

Motif Bio

19 Mar 2020 17:30

RNS Number : 8768G
FTSE Russell
19 March 2020
 

 

Motif Bio (UK): Constituent DeletionChanges in FTSE UK Index Series

19 March 2020

Following the reclassification to AIM Rule 15 (Cash Shell) for Motif Bio (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

24 March 2020

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSUKSNRRSUOAAR
12345678
Date   Source Headline
14th Sep 201611:15 amRNSIssue of Equity
8th Sep 20167:00 amRNSRe-negotiation of the terms of the CPNs
8th Sep 20167:00 amRNSUPDATE ON REVIVE-1 PHASE 3 CLINICAL TRIAL
26th Aug 20167:00 amRNSChief Medical Officer presents at congress in USA
22nd Aug 20164:31 pmRNSDirector/PDMR Shareholding
16th Aug 20167:00 amRNSHalf-year Report
9th Aug 20165:24 pmRNSHolding(s) in Company
9th Aug 20167:00 amRNSUpdate on timing of proposed US Public Offering
5th Aug 20167:00 amRNSHolding(s) in Company
1st Aug 20162:15 pmRNSResult of General Meeting
28th Jul 20164:22 pmRNSPreliminary prospectus filed
18th Jul 20164:38 pmRNSDirector/PDMR Shareholding
13th Jul 20167:01 amRNSCircular to allot shares for proposed US Offering
13th Jul 20167:01 amRNSNotice of Intention to List on NASDAQ by Motif Bio
13th Jul 20167:00 amRNSFiles For Proposed U.S. Public Offering
1st Jul 20167:00 amRNSDirectorate Change
2nd Jun 20163:37 pmRNSResult of AGM
1st Jun 20167:00 amRNSCEO to Present at BIO 2016
24th May 20167:00 amRNSInvestor presentation
28th Apr 20167:03 amRNSRe. Amphion Innovations plc
25th Apr 20167:00 amRNSReplay for Analyst & Investor Conference Call
22nd Apr 20167:00 amRNSGrant of Options
21st Apr 20167:00 amRNSAnnual Report and Accounts 2015
20th Apr 20167:00 amRNSFinal Results
18th Apr 20167:00 amRNSResults Conference Call Details
14th Apr 20167:00 amRNSSenior Appointments
23rd Mar 20167:00 amRNSMotif Bio to present at BIO-Europe Spring
14th Mar 20167:00 amRNSAppointment of strategic adviser
2nd Mar 20167:00 amRNSFirst patient dosed in iclaprim Phase 3 trials
23rd Feb 20165:39 pmRNSHolding(s) in Company
22nd Feb 20167:00 amRNSWebcast on Combating antibiotic resistance
25th Jan 20167:00 amRNSAppointments of U.S. finance adviser and auditor
22nd Dec 20157:00 amRNSExercise of Warrants
15th Dec 20157:00 amRNSIclaprim Clinical Trial Supplies Manufactured
7th Dec 20157:00 amRNSMotif selected to present at Biotech Showcase
24th Nov 20157:00 amRNSReceipt of FDA Concurrence
11th Nov 20157:00 amRNSEuropean Agreement for Iclaprim Development
27th Oct 20157:00 amRNSSelected to Present at BIO-Europe 2015
21st Oct 20157:00 amRNSExercise of Options
16th Oct 20157:00 amRNSLeading CRO to Conduct Iclaprim Phase III Trials
13th Oct 20157:00 amRNSResults of Two Posters on Iclaprim at ID Week 2015
12th Oct 20153:59 pmRNSExercise of Options
5th Oct 20154:41 pmRNSDirectors Dealings
29th Sep 20157:01 amRNSPresentation of Two Posters on Iclaprim
23rd Sep 20153:04 pmRNSIssue of Shares for Exercised Warrants
3rd Sep 20157:00 amRNSFDA Grants Fast Track Designation for Iclaprim
2nd Sep 20157:00 amRNSParticipation at Upcoming Investor Events
2nd Sep 20157:00 amRNSAppointment of IR Adviser
27th Aug 20157:01 amRNSInterims Results for the 6 months to 30 June 2015
24th Aug 20157:00 amRNSPotent Efficacy of Iclaprim Confirmed
12345678

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
JEFI
JEFI.L
LSE
0.00%
MATE
MATE.L
LSE
0.00%
INFI
INFI.L
LSE
0.00%
IAG
International Airlines
LSE
-1.55%
VIC
Victorian Plumbing
LSE
-1.50%
Trending
GGP
Greatland Resources
LSE
-1.71%
DFDV
Defi Dev Corp
LSE
158.26%
IMM
Immupharma
LSE
3.09%
NTVO
Nativo Resources
LSE
-15.38%
QBT
Quantum Block
LSE
0.00%